The Canadian Government
|April 24, 2023
|14:45 – 15:30
Breaking Boundaries: The Emergence of Regenerative Medicine, Digital Technologies and Genomics
Focusing on scientific opportunities, this panel discussion is looking to exchange of ideas between leading biotech nation, foster greater collaboration across the entire ecosystem and highlight some of the most exciting current and future developments in addressing unmet diseases.
Mr. Nicholas Franco, Former EVP and Chief Business Development Officer Johnson & Johnson
Dr. Michael May, President and Chief Executive Officer, Centre for Commercialization of Regenerative Medicine
Dr. Rob Annan, President and Chief Executive Officer, Genomics Canada
Dr. Raphaëlle Luisier, Group Leader at Idiap Research Institute, Swiss Institute of Bioinformatics
Mrs. Avaleigh Milne, Head of Business Development for Pharma Research and Early Development at Roche
Invest in Canada works directly with global investors to unlock investment opportunities and facilitate expansion in Canada. We bring industry, community and government partners together to offer seamless services that make it easy for you to grow your operations in Canada.